These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26233769)

  • 41. Estimating the proportion of Danes at high risk of fatal cardiovascular disease.
    Holm AS; Olsen GS; Borglykke A; Jørgensen T
    Scand J Public Health; 2011 Aug; 39(6):571-6. PubMed ID: 21737477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Machine learning methodologies versus cardiovascular risk scores, in predicting disease risk.
    Dimopoulos AC; Nikolaidou M; Caballero FF; Engchuan W; Sanchez-Niubo A; Arndt H; Ayuso-Mateos JL; Haro JM; Chatterji S; Georgousopoulou EN; Pitsavos C; Panagiotakos DB
    BMC Med Res Methodol; 2018 Dec; 18(1):179. PubMed ID: 30594138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
    Perna L; Schöttker B; Holleczek B; Brenner H
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4908-15. PubMed ID: 24106288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Aug; 43(8):437-444. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary.
    Timmis A; Vardas P; Townsend N; Torbica A; Katus H; De Smedt D; Gale CP; Maggioni AP; Petersen SE; Huculeci R; Kazakiewicz D; Rubio VB; Ignatiuk B; Raisi-Estabragh Z; Pawlak A; Karagiannidis E; Treskes R; Gaita D; Beltrame JF; McConnachie A; Bardinet I; Graham I; Flather M; Elliott P; Mossialos EA; Weidinger F; Achenbach S
    Eur Heart J Qual Care Clin Outcomes; 2022 Jun; 8(4):377-382. PubMed ID: 35488372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European Society of Cardiology: Cardiovascular Disease Statistics 2017.
    Timmis A; Townsend N; Gale C; Grobbee R; Maniadakis N; Flather M; Wilkins E; Wright L; Vos R; Bax J; Blum M; Pinto F; Vardas P;
    Eur Heart J; 2018 Feb; 39(7):508-579. PubMed ID: 29190377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study.
    Graversen P; Abildstrøm SZ; Jespersen L; Borglykke A; Prescott E
    Eur J Prev Cardiol; 2016 Sep; 23(14):1546-56. PubMed ID: 26976846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
    Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New Way to "SCORE" Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines.
    Graham IM; Di Angelantonio E; Huculeci R;
    Curr Cardiol Rep; 2022 Nov; 24(11):1679-1684. PubMed ID: 36441402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling anthropometric indices in relation to 10-year (2002-2012) incidence of cardiovascular disease, among apparently healthy individuals: The ATTICA study.
    Filippatos TD; Kyrou I; Georgousopoulou EN; Chrysohoou C; Kouli GM; Tsigos C; Tousoulis D; Stefanadis C; Pitsavos C; Panagiotakos DB
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S789-S795. PubMed ID: 28606442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study.
    Luijten J; van Greevenbroek MMJ; Schaper NC; Meex SJR; van der Steen C; Meijer LJ; de Boer D; de Graaf J; Stehouwer CDA; Brouwers MCGJ
    Atherosclerosis; 2019 Jan; 280():1-6. PubMed ID: 30448567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study.
    Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicted 10-year risk of cardiovascular mortality in the 40 to 69 year old general population without cardiovascular diseases in Germany.
    Diederichs C; Neuhauser H; Rücker V; Busch MA; Keil U; Fitzgerald AP; Heuschmann PU
    PLoS One; 2018; 13(1):e0190441. PubMed ID: 29293619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
    van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece.
    Touloumi G; Kalpourtzi N; Papastamopoulos V; Paparizos V; Adamis G; Antoniadou A; Chini M; Karakosta A; Makrilakis K; Gavana M; Vantarakis A; Psichogiou M; Metallidis S; Sipsas NV; Sambatakou H; Hadjichristodoulou C; Voulgari PV; Chrysos G; Gogos C; Chlouverakis G; Tripsianis G; Alamanos Y; Stergiou G;
    PLoS One; 2020; 15(3):e0230730. PubMed ID: 32226048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neck circumference and future cardiovascular events in a high-risk population--A prospective cohort study.
    Dai Y; Wan X; Li X; Jin E; Li X
    Lipids Health Dis; 2016 Mar; 15():46. PubMed ID: 26946432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of healthy ageing and its relation to 10-year cardiovascular disease incidence: the ATTICA study.
    Kollia N; Panagiotakos DB; Chrysohoou C; Georgousopoulou E; Tousoulis D; Stefanadis C; Papageorgiou C; Pitsavos C
    Cent Eur J Public Health; 2018 Mar; 26(1):3-9. PubMed ID: 29684290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
    Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.
    Veronesi G; Gianfagna F; Giampaoli S; Chambless LE; Grassi G; Cesana G; Ferrario MM
    Eur J Prev Cardiol; 2015 Dec; 22(12):1618-25. PubMed ID: 25501263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.